Skip to main content

New Products: Knome's KnomeClinic

Premium

Knome has begun an early-access program for knomeClinic, a software suite designed to help medical researchers and clinicians interpret human genomes.

The company said that clinics accepted into the program will be given "installation priority, access to pilot programs and pre-release prototypes, and the ability to influence knomeClinic's feature set upon general release."

The knomeClinc suite is built upon the company's kGAP informatics and annotation platform, which accepts raw sequence data from major sequencing platforms and generates standardized, annotated data sets.

Knome has not provided a timeline for the commercial release of knomeClinic, but said that when it is available it will include desktop interpretation-support applications; a database of curated reference data containing more than 100,000 genotype-phenotype associations; and software that will allow researchers, physicians, and medical institutions to "curate and prioritize genotype-phenotype associations, whether publically available or self-generated."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.